BIOSTROKE Meeting 2026
The 2nd BIOSTROKE meeting took place at
Hohenkammer castle from February 23 to 25, 2026.
We thank all speakers, poster presenters, and participants for their contributions and the very fruitful, interesting discussions. We look forward to the strong science built on BIOSTROKE collaborations. Thanks to our funders (DFG, UoC, ISCBFM) and sponsors (Merck, CSL, Quanterix) for their support!
We look forward to welcoming you all again in 2027!
PHOTOS FROM THE EVENT
ORGANIZING TEAM
University College
Dublin, Ireland
University of Calgary, Canada
Institute for Stroke &
Dementia Research, LMU Hospital Munich, Germany
BIOSTROKE Meeting 2026
BIOSTROKE offers a unique platform to advance biomarker science in stroke care and foster interdisciplinary collaboration between experts in stroke biomarker research, cardiovascular medicine, and neuroscience.
Bringing together around 120 participants, the BIOSTROKE meeting 2026 facilitated in-depth scientific exchange on the most pressing, unsolved challenges in clinical decision-making with sessions across the stroke care continuum – from prehospital management to secondary prevention and long-term recovery. The program featured talks by internationally recognized leaders, alongside presentations selected from submitted abstracts. The format prioritized open discussion and informal interactions among scientists of all career levels.
BIOSTROKE 2026 was endorsed by the European Stroke Organization (ESO) and the European Society of Minimally Invasive Neurological Therapy (ESMINT). CME/CPD accreditation is currently in process.
PROGRAM
VENUE
Hohenkammer Castle
(Schloss Hohenkammer, 40 km from Munich city center)
Schlossstrasse 18 – 25
85411 Hohenkammer, Germany